
In a comparative study involving over 105,000 women, researchers found the use of adjunctive AI for mammography triage resulted in a 16 percent lower rate of invasive interval cancers in comparison to double reading by radiologists without AI.
Senior Editor, Diagnostic Imaging

In a comparative study involving over 105,000 women, researchers found the use of adjunctive AI for mammography triage resulted in a 16 percent lower rate of invasive interval cancers in comparison to double reading by radiologists without AI.

The Biograph One PET/MRI system may facilitate accelerated scan times, improved visualization and more efficient assessments of theranostic approaches for patients with oncologic and neurological diseases.

In a new podcast episode, Kernesha Weatherly, DHA, emphasized the importance of communication with radiologists, ordering providers and patients to identify challenges with follow-up of incidental imaging findings, and how AI helped bolster data and “line of sight” in these cases at Ochsner Health.

Employing AI-powered automation, the MIM LesionID™ Pro reportedly bolsters the efficiency of whole-body tumor burden analysis with PSMA PET/CT and SPECT/CT.

For young women with breast cancer, peritumoral edema on pre-op breast MRI was associated with over a 3.6-fold higher likelihood for reduced disease-free survival, according to new research.

Employing latent profile analysis (LPA) to help assess body fat distribution patterns, researchers found that a pancreatic-predominant profile with elevated proton density fat fraction derived from MRI was associated with extensive gray matter atrophy and cognitive decline.

The use of 5T prostate MRI offered significantly higher signal-to-noise ratio (SNR) than 3T prostate MRI as well as enhanced delineation with T2-weighted and diffusion-weighted imaging, according to newly published comparative research.

Catch up on the top radiology content of the past week.

Sharing his insights as well as findings from recent research, Mina Makary, M.D., discussed pertinent challenges with diversity and resident attrition rates in interventional radiology and possible approaches to address these issues.

A prospective research comparison of ultra-low-dose (ULD) PCCT and low-dose (LD) PCCT protocols yielded comparable image quality and strong agreement on emphysema severity assessments with ULD PCCT offering significantly reduced radiation dosing.

Employing low pressure ultrasound treatment to break up kidney stones, the Break Wave lithotripsy device offers a non-invasive, anesthesia-free alternative

In recent interviews, Rajesh Bhayana, M.D., Manisha Bahl, M.D., and Jeremie Calais, M.D., Ph.D., shared their thoughts on agentic AI, key directions in breast imaging research and emerging trends with prostate cancer theranostics in 2026.

Geared toward facilitating earlier detection and efficiencies in emergency department workflow, the AI triage software reportedly has 11 newly cleared indications.

In a prospective comparison with prior criteria for evaluating hepatocellular carcinoma surveillance, the American Association for the Study of Liver Diseases (AASLD) version 2023 system offered significantly higher sensitivity.

In a recent interview, Manisha Bahl, M.D., discussed recent research demonstrating a significant decline in the sensitivity of digital breast tomosynthesis (DBT) with increasing breast density as well as challenges in the utilization of supplemental imaging for women with dense breasts.

In a seven study meta-analysis with a total of 493 cases involving high-risk breast lesions, researchers found that contrast-enhanced breast MRI did not miss any cases of invasive breast cancer.

In a recent interview, David Yankelevitz, M.D., discussed the recent FDA clearance of the AI-CVD multisystem screening software and the ongoing evolution of incorporating computed tomography into personalized screening and risk assessments.

Incorporating AI to reduce artifacts and bolster soft tissue contrast, the Elekta Evo CT-Linac system reportedly improves detection of tumors and organs-at-risk.

Catch up on the top radiology content of the past week.

Offering an echogenic cutting cannula and enhanced sampling capability, the EnCor EnCompass Breast Biopsy and Tissue Removal System reportedly enables biopsy procedures across different breast imaging platforms.

From satisfaction of search to grouped microcalcifications and challenges with isodense asymmetries and blind spots, the authors of a new review discuss contributing factors and preventive measures to avoid missed diagnoses of breast cancer in mammography interpretation.

In a recent interview, Rajesh Bhayana, M.D., discussed pertinent findings from a new study examining the use of the large language model GPT-4o in facilitating protocoling for abdominal and pelvic CT exams.

Offering a biocompatible, non-metallic alternative to metallic tumor markers, the VM1 tumor marker reportedly offers artifact-free visibility across a variety of breast imaging including mammography, ultrasound and MRI.

In what may be the largest study to assess digital breast tomosynthesis (DBT) screening of women with dense breasts, researchers noted only a 61.8 percent sensitivity for women with extremely dense breasts.

In a recent interview, Mina Makary, M.D., discussed recent research examining diversity within interventional radiology (IR), attrition rates in IR residency programs and potential strategies to bolster recruitment and retention.

After a causal mediation analysis that adjusted for breast density, researchers found that Black women had a significantly higher likelihood of high MRI-derived background parenchymal enhancement (BPE) than White women in a study involving nearly 2,500 women.

Offering compact versatility for an array of clinical settings, the ASUS Handheld Ultrasound LU800 is reportedly the first handheld device to be supported across Android, Chrome, iOS and Windows operating systems.

In a recent interview, Ron Blankstein, M.D., discussed insights from a recent consensus statement from the American College of Cardiology on AI-enabled plaque quantification with coronary computed tomography angiography (CCTA) exams, and other pertinent considerations with the emerging technology.

The AI-CVD software reportedly combines automated quantitative measurements for cardiovascular assessments such as coronary artery calcium (CAC) scoring and epicardial fat volumetry with lung attenuation and liver attenuation analysis in one CT-based AI platform.

Catch up on the top radiology content of the past week.